Eric S Winer

13PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

|Oct 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Nov 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia.

Marlise R Luskin, Shai Shimony, Julia Keating

|Oct 17, 2024
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy.

Geoffrey L Uy, Vinod Pullarkat, Praneeth Baratam

|Oct 07, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.

Marlise R Luskin, Mark A Murakami, Julia Keating

Pageof 3

Frequent Collaborators

11 joint publications

Jacqueline S Garcia

11 joint publications

Marlise R Luskin

7 joint publications

Daniel J DeAngelo

5 joint publications

Rahul Vedula